Enhancing Immune Health Randomized Controlled Trial
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Dec 2, 2022
Trial Information
Current as of January 17, 2025
Recruiting
Keywords
ClinConnect Summary
The Enhancing Immune Health Randomized Controlled Trial is a research study aimed at helping adults with serious mental illnesses improve their understanding and behaviors related to immune health. The study is exploring a special program designed to teach participants about how to take care of their immune system, which is important for overall health. This trial is currently recruiting participants aged 18 and older who are members of a community mental health agency and have access to the Internet.
To be eligible for the study, participants must have a serious mental illness and be able to provide informed consent, meaning they understand what the study involves and agree to take part. Unfortunately, individuals who have severe cognitive difficulties that prevent them from giving informed consent or who cannot communicate in English cannot participate. Those who join the study can expect to engage in activities that will help them learn about immune health, and their progress will be monitored throughout the trial. This research could provide valuable insights into how to better support the health of individuals with mental illnesses.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 and older
- • Serious mental illness
- • Membership in a collaborating community mental health agency
- • Access to the Internet
- • Able to provide informed consent
- Exclusion Criteria:
- • Cognitive impairment preventing informed consent
- • Unable to communicate in English
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials